Cargando…
Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
Autores principales: | Xu, Keman, Zhang, Yuling, Saaoud, Fatma, Shao, Ying, Lu, Yifan, Jiang, Xiaohua, Wang, Hong, Yang, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151803/ https://www.ncbi.nlm.nih.gov/pubmed/37144060 http://dx.doi.org/10.3389/fcvm.2023.1184030 |
Ejemplares similares
-
Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022
por: Xu, Keman, et al.
Publicado: (2023) -
Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022) -
Editorial: Insights in cardiovascular imaging: 2022
por: Kelle, Sebastian, et al.
Publicado: (2023) -
Editorial: Insights in cardiovascular epidemiology and prevention: 2022
por: Lin, Gen-Min
Publicado: (2023) -
Editorial: Insights in general cardiovascular medicine: 2022
por: Acampa, Maurizio, et al.
Publicado: (2023)